DOCSLIB.ORG

BIDMC Department of Medicine 2019 Annual Report BIDMC Department of Medicine 2019 Annual Report / 3 Departmental Organization

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
BIDMC Department of Medicine 2019 Annual Report BIDMC Department of Medicine 2019 Annual Report / 3 Departmental Organization Always at the cutting edge Department of Medicine 2019 Annual Report Acknowledgments The Department of Medicine would like to extend gratitude to the many people who contributed to this report, including Department leadership, Division Chiefs, administrators, and faculty members. We also thank Gigi Korzenowski and Jerry Clark of Korzenowski Design, and Kallie Gregg and Sophie Afdhal of the Department of Medicine. Much of the photography and photo research for this report were conducted by BIDMC’s James Derek Dwyer and Danielle Duffey. Jane Hayward, Lindsay Oslund, Heather Derocher, and Ann Plasso all provided expert copy editing and design consultation. We also thank the Communications and Marketing Department. Last but not least, we wish to thank all of the individuals featured in these pages for their collaboration and for all they do for the Department of Medicine, our patients, and the medical center. Table of Contents Acknowledgments ............................................................2 Leading Minds: Education at Harvard Medical School ................................................24 From the Chair ...................................................................4 Early Investigator, Timely Advances: Departmental Organization .........................................4 Sol Schulman, MD, PhD ..................................................28 From the CAO ....................................................................5 Exceptional Mentorship and Career Development, Supporting New Leadership ................................................................9 Cutting-Edge Research ..................................................30 Vice Chair Updates ...........................................................8 Cutting-Edge Conversations .........................................34 Breaking Ground on a Cutting-Edge Medical Education Leadership ....................................36 New Inpatient Building ...................................................12 Selected Publications ......................................................37 Coming Together as a New System ............................14 Research Funding: A Pioneer of Perception: Academic Year 2018-2019 ..............................................44 Mark Andermann, PhD ...................................................16 In Memoriam .....................................................................45 Awards & Honors ..............................................................18 Clinical Volume at the Cutting Edge ...........................20 Taking Bedside Rounds Anywhere and Everywhere ................................................................22 This report is interactive. Navigate using the Table of Contents above and the links throughout the report. 2 / BIDMC Department of Medicine 2019 Annual Report BIDMC Department of Medicine 2019 Annual Report / 3 Departmental Organization As of 2020 From the Chair Administration Clinical Divisions Research Divisions From the CAO Since coming together as part of Beth Israel Lahey Health As I write this message, we are completing a several month Mark Zeidel, MD ALLERGY AND INFLAMMATION HEMATOLOGY AND CLINICAL INFORMATICS last year (for more information, visit page 14), the Department journey through the first—and we hope the only—crisis phase Department Chair HEMATOLOGIC MALIGNANCIES Peter Weller, MD Yuri Quintana, PhD of Medicine has been proud to be an integral part of the new of the COVID-19 pandemic. The report in your hands describes David Avigan, MD Kevin Maguire, MS Division Chief Division Chief system as we continue to emphasize our mission: providing the achievements of one of America’s premier Departments of Division Chief Chief Administrative Officer Amanda Yano-Litwin, MHA extraordinary care to our patients, training the next generation Medicine prior to the onset of the COVID-19 epidemic. CLINICAL NUTRITION Mark Aronson, MD Division Administrator Christine VanDeWege, MA of physicians and scientists, and engaging in groundbreaking Bruce Bistrian, MD, PhD, MPH During this past academic year, the Department continued Vice Chair, Quality Division Administrator research across all of our Divisions. its tradition of providing superb, high quality care to ever- CARDIOVASCULAR MEDICINE Division Chief Donald Cutlip, MD INFECTIOUS DISEASES It has been an incredibly eventful beginning for our new system, increasing numbers of outpatients and inpatients, both on Robert Gerszten, MD Vice Chair, Clinical Care EXPERIMENTAL MEDICINE and I could not be more proud of how BILH and the Department BIDMC’s main campus and at an ever-growing number Division Chief Peter Weller, MD of Medicine has responded to the many challenges we faced and of community health centers. We continued to expand our in the Community Division Chief Jerome Groopman, MD John DiGiorgio, MPS-HHS continue to face. structural heart and congestive heart failure programs, we Grace Huang, MD Division Chief Division Administrator Amanda Yano-Litwin, MHA enhanced our interdepartmental collaborative efforts in Vice Chair, Career Throughout the entire coronavirus pandemic, from our early Division Administrator HEMOSTASIS AND THROMBOSIS transplantation, and we continued to expand our innovative Development and Mentoring ENDOCRINOLOGY, preparedness plans and managing the surge in Massachusetts, approaches towards immunotherapy in cancer care. At the DIABETES AND METABOLISM MEDICAL ONCOLOGY Robert Flaumenhaft, MD, PhD to recovering and beginning to adapt to a ‘new normal,’ the Barbara Kahn, MD Division Chief Department acted quickly, effectively, and collaboratively to care same time, we continued the planning for our new inpatient Vice Chair, Research Strategy Evan Rosen, MD, PhD David F. McDermott, MD building and we have accelerated our collaborative clinical Division Chief Division Chief for our patients and for one another during unprecedented times. Eileen Reynolds, MD IMMUNOLOGY efforts throughout the Beth Israel Lahey Health network. Every member of our Department contributed to managing Vice Chair, Education Amanda Yano-Litwin, MHA Christine VanDeWege, MA Cornelius Terhorst, PhD Our educators led the way in developing new curricula at this crisis: the Vaccine and Virology lab is at the forefront of the Division Administrator Division Administrator Division Chief Harvard Medical School and continued to recruit and train C. Christopher Smith, MD race to develop a vaccine, faculty provided surge coverage superb classes of interns, residents, and fellows. Again, our Associate Vice Chair, GASTROENTEROLOGY NEPHROLOGY INTERDISCIPLINARY MEDICINE for inpatient COVID-19 floors, staff converted clinical spaces to Education educators were honored repeatedly for their dedication, Nezam Afdhal, MD Martin Pollak, MD AND BIOTECHNOLOGY accommodate additional patients on ventilators, and residents ingenuity, and effectiveness. developed a program to donate iPads to connect loved ones with Anjala Tess, MD Division Chief Division Chief Ary Goldberger, MD isolated patients. These are just a few examples, among many, Our researchers continued to break new ground in cancer, Associate Vice Chair, Division Chief Sara Montanari Kerry Falvey that demonstrate the versatility, talent, and commitment we have vaccine development, rheumatologic, metabolic, renal, Education Division Administrator Division Administrator within the Department and at BIDMC. and cardiac diseases, and we continued to strengthen Peter Weller, MD SIGNAL TRANSDUCTION our mentoring of young investigators and junior faculty Vice Chair, Research GENERAL MEDICINE PULMONARY, CRITICAL Alex Toker, PhD It’s been a year of ups and downs met by change and innovation, members of all types. We welcomed Gyongyi Szabo, BIDMC’s CARE AND SLEEP MEDICINE and I’m eager to see what the coming months bring for the Tim McDermott, MHA Eileen Reynolds, MD Division Chief new Chief Academic Officer, to our Department. As a truly Richard Schwartzstein, MD Department of Medicine, BIDMC, and Beth Israel Lahey Health. Executive Director, Finance Division Chief outstanding Hepatologist and liver investigator, Dr. Szabo will Division Chief TRANSLATIONAL RESEARCH I hope you are as well. and Business Operations Blair Bisher, MHA AND TECHNOLOGY INNOVATION collaborate with Dr. Afdhal and colleagues in the Division of Renee Wheeler Paul Hart Miller Division Administrator Gastroenterology, Hepatology and Nutrition to further develop a Division Administrator Steven Freedman, MD, PhD comprehensive liver research program of international stature. Director, Business GERONTOLOGY Division Chief and Network Development RHEUMATOLOGY AND Although this Annual Report describes the year’s events prior Lewis Lipsitz, MD CENTER FOR VIROLOGY Scot Sternberg, MS CLINICAL IMMUNOLOGY to the pandemic, reflecting on the past year from this new Division Chief AND VACCINE RESEARCH Kevin Maguire, MS, perspective renews the pride we have in our missions and our Director, Quality Improvement George Tsokos, MD Chief Administrative Officer, Kerry Falvey confidence that these missions will endure and flourish, no Division Chief Dan Barouch, MD, PhD Department of Medicine Division Administrator Division Chief matter what challenges the pandemic has in store. Patricia Harris Division Administrator Mark L. Zeidel, MD Chair, Department of Medicine 4 / BIDMC Department of Medicine 2019 Annual Report BIDMC Department of Medicine 2019 Annual Report / 5 New Leadership in many clinical innovations in the potent induction of anti- role, Dr. McDermott will serve
Load more

Recommended publications
  • Plasma Proteomics of COVID-19 Associated Cardiovascular Complications: Implications for Pathophysiology and Therapeutics
    Plasma Proteomics of COVID-19 Associated Cardiovascular Complications: Implications for Pathophysiology and Therapeutics Jason Roh Harvard Medical School Robert Kitchen Harvard Medical School https://orcid.org/0000-0003-1443-8559 J Sawalla Guseh Massachusetts General Hospital Jenna McNeill Massachusetts General Hospital Malika Aid Beth Israel Deaconess Medical Center BIDMC Amanda Martinot Tufts University https://orcid.org/0000-0001-6237-6191 Andy Yu Massachusetts General Hospital Colin Platt Massachusetts General Hospital James Rhee Massachusetts General Hospital Brittany Weber Brigham and Women's Hospital Lena Trager Massachusetts General Hospital Margaret Hastings Massachusetts General Hospital Sarah Ducat Tufts University https://orcid.org/0000-0002-5285-7642 Peng Xia Massachusetts General Hospital Claire Castro Massachusetts General Hospital Bjarni Atlason Page 1/26 Massachusetts General Hospital Timothy Churchill Massachusetts General Hospital Marcelo Di Carli Brigham and Women's Hospital Patrick Ellinor The Broad Institute of MIT and Harvard https://orcid.org/0000-0002-2067-0533 Dan Barouch Beth Israel Deaconess Medical Center https://orcid.org/0000-0001-5127-4659 Jennifer Ho Massachusetts General Hospital Anthony Rosenzweig ( [email protected] ) Massachusetts General Hospital Article Keywords: COVID-19, cardiovascular complications, disease severity, mortality Posted Date: June 8th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-539712/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 2/26 Abstract Cardiovascular complications are common in COVID-19 and strongly associated with disease severity and mortality. However, the mechanisms driving cardiac injury and failure in COVID-19 are largely unknown. We performed plasma proteomics on 80 COVID-19 patients and controls, grouped according to disease severity and cardiac involvement.
    [Show full text]
  • A MODEL PATIENT JEROME GROOPMAN Four Students in Their
    A MODEL PATIENT JEROME GROOPMAN Four students in their third year at Harvard Medical School recently met a patient named Mr. Martin. The students’ mentors, two physicians, told them that Martin had come to the emergency room complaining of abdominal pain that had grown steadily worse over several days. Martin was lying on a stretcher, moaning. A monitor next to the stretcher indicated that his blood pressure was dangerously low—eighty over fifty-four—and his heart was racing at a hundred and eighteen beats per minute. An X-ray mounted on a light box on the wall showed loops of distended bowel, called an ileus. The intestine can swell like this when it is obstructed or inflamed. “It hurts!” Martin cried as the students reviewed his chart. “They told me you’d give me something for the pain.” “Should we give him something?” one student asked. “I guess so,” another replied. The first student emptied a syringe of morphine into an intravenous line attached to Martin’s arm. Within a few seconds, Martin stopped moaning. Then the monitor started to beep rapidly. Martin had stopped breathing. The syringe had contained twenty milligrams of morphine, a potentially lethal dose for someone in his condition. The students began to perform CPR. One passed an endotracheal tube through Martin’s vocal cords into his airway. Another began to pump oxygen into the tube. Dr. Nancy Oriol, the dean of students at Harvard Medical School, showed me a videotape of the students’ encounter with Martin. “The students didn’t figure it out,” she said.
    [Show full text]
  • Arxiv:2003.13670V4 [Cs.CY] 3 Apr 2020 IV Program
    Anonymous Collocation Discovery: Harnessing Privacy to Tame the Coronavirus∗ Ran Canetti† Ari Trachtenberg‡ Mayank Varia§ Boston University April 7, 2020 Abstract Successful containment of the Coronavirus pandemic rests on the ability to quickly and reliably identify those who have been in close proximity to a contagious individual. Existing tools for doing so rely on the collection of exact location information of individuals over lengthy time periods, and combining this information with other personal information. This unprecedented encroachment on individual privacy at national scales has created an outcry and risks rejection of these tools. We propose an alternative: an extremely simple scheme for providing fine-grained and timely alerts to users who have been in the close vicinity of an infected individual. Crucially, this is done while preserving the anonymity of all individuals, and without collecting or storing any personal information or location history. Our approach is based on using short-range communication mechanisms, like Bluetooth, that are available in all modern cell phones. It can be deployed with very little infrastructure, and incurs a relatively low false-positive rate compared to other collocation methods. We also describe a number of extensions and tradeoffs. We believe that the privacy guarantees provided by the scheme will encourage quick and broad voluntary adoption. When combined with sufficient testing capacity and existing best practices from healthcare professionals, we hope that this may significantly reduce the infection rate. To avoid confusion, we stress that this work does not propose any direct medical treatment. arXiv:2003.13670v4 [cs.CY] 3 Apr 2020 Rather, it proposes a way to pool together information from the community in order to help (a) direct medical personnel in how to best allocate and use testing resources, and (b) direct individuals as to when to get tested and self-quarantine.
    [Show full text]
  • Kathy Giusti and the Multiple Myeloma Research Foundation
    9-814-026 JUNE 25, 2014 RICHARD G. HAMERMESH JOSHUA D. MARGOLIS MATTHEW G. PREBLE Kathy Giusti and the Multiple Myeloma Research Foundation This is the model for cancer. It is the model for medicine; of what we have to do.1 — Eric Lander, founding director of the Broad Institute Kathy Giusti (HBS ’85) was driving home one evening in January 1996 when she got the call from her doctor.2 He asked if Giusti and her husband Paul (HBS ’85) could come to his office.3 Sensing bad news, Giusti wanted to know what was wrong.4 Her doctor relented and told Giusti that she had multiple myeloma (MM), a rare and fatal cancer.5 Early the next morning, Giusti went to a bookstore near her Chicago, Illinois home and headed for the medical section.6 “We were going through these books, and I started thinking ‘Oh my God, what just happened to my life,’” she recalled. After her appointment, Giusti’s worst fears were confirmed. She could expect to live for just a few more years—three or four at the most. Up to that moment everything seemed to be going as planned.7 Since graduating from Harvard Business School (HBS) just over a decade earlier, Giusti had had one career success after another. At the time of her diagnosis, she was the executive in charge of global operations for G.D. Searle & Co.’s (Searle) arthritis drugs division.8 The Giustis had recently had their first child and just started trying to have a second.9 Now, all was in flux.
    [Show full text]
  • In Their Own Words
    DEPARTMENT OF MEDICINE ANNUAL REPORT 2017 Department of Medicine Beth Israel Deaconess Medical Center 330 Brookline Avenue, Boston, MA 02215 617-667-7000 bidmc.org/medicine IN THEIR OWN WORDS Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. BIDMC is in the community with Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess Hospital-Plymouth, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Healthcare, Beth Israel Deaconess HealthCare, Community Care Alliance and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew SeniorLife and is a research partner of Dana-Farber/Harvard Cancer Center and The Jackson Laboratory. BIDMC is the official hospital of the Boston Red Sox. For more information, visit www.bidmc.org. The Department of Medicine wishes to thank the many individuals who contributed to this report, including department and division leaders. We also thank Gigi Korzenowski and Jerry Clark of Korzenowski Design, and Jennie Greene, Meera Kanabar, and Jacqueline St. Onge of the Department of Medicine. The photography in this report was done by BIDMC’s Jim Dwyer and Danielle Duffey, who also helped with photo research. Jane Hayward, of BIDMC Media Services, provided expert copy editing and design consultation. We also thank several members of the Development and Communications Departments for their input. Last but not least, we wish to thank all of the individuals featured in these pages for contributing their time and perspectives to this year’s annual report.
    [Show full text]
  • Southern California Public Radio- FCC Quarterly Programming Report July 1- September 30,2016 KPCC-KUOR-KJAI-KVLA-K227BX-K210AD S
    Southern California Public Radio- FCC Quarterly Programming Report July 1- September 30,2016 KPCC-KUOR-KJAI-KVLA-K227BX-K210AD START TIME DURATION ISSUE TITLE AND NARRATIVE 7/1/2016 Take Two: Border Patrol: Yesterday, for the first time, the US Border patrol released the conclusions of that panel's investigations into four deadly shootings. Libby Denkmann spoke with LA Times national security correspondent, Brian Bennett, 9:07 9:00 Foreign News for more. Take Two: Social Media Accounts: A proposal floated by US Customs and Border Control would ask people to voluntarily tell border agents everything about their social media accounts and screen names. Russell Brandom reporter for The Verge, spoke 9:16 7:00 Foreign News to Libby Denkmann about it. Law & Order/Courts/Polic Take Two: Use of Force: One year ago, the LAPD began training officers to use de-escalation techniques. How are they working 9:23 8:00 e out? Maria Haberfeld, professor of police science at John Jay College of Criminal Justice spoke to A Martinez about it. Take Two: OC Refugee dinner: After 16 hours without food and water, one refugee family will break their Ramadan fast with mostly strangers. They are living in Orange County after years of going through the refugee process to enter the United States. 9:34 4:10 Orange County Nuran Alteir reports. Take Two: Road to Rio: A Martinez speaks with Desiree Linden, who will be running the women's marathon event for the US in 9:38 7:00 Sports this year's Olympics. Take Two: LA's best Hot dog: We here at Take Two were curious to know: what’s are our listeners' favorite LA hot dog? They tweeted and facebooked us with their most adored dogs, and Producers Francine Rios, Lori Galarreta and host Libby Denkmann 9:45 6:10 Arts And Culture hit the town for a Take Two taste test.
    [Show full text]
  • Inspirations from the Field the Proverbial
    The Newsletter of The Arnold P. Gold Foundation A Public Foundation Dedicated to Fostering Humanism in Medicine Thanksgiving 1999 The Proverbial Inspirations from the field Last Straw! It was a proverbial “last straw” that brought us to Dr. Arnold Gold’s office, “TheWhite Coat–Just in 1995. A few days before our son an item of clothing!! Anthony was to become a first grader, he rushed towards me and the force of Yet we endow it with great his impact knocked me against a wall in symbolism and power. our house,driving my hand into the skin of my face,narrowly missing my eye. When I told my mother about this speech, she told me a story that she had This was only the latest in a number of never shared with me before. My physical “accidents” in which he hurt me, father was a patient in the hospital and for which he would later apologize. where I was a resident. She remembers Anthony had been discharged from two seeing me walking down the hall Members of the Mercer University School of Medicine, child-care centers by age four, not for towards my father’s room. I was dressed Class of 2003, recite the Oath of Geneva during the School’s aggression but for not listening to the August 8, 1999 White Coat Ceremony in Macon, Georgia. in my white coat with a group of distin- teacher and/or being uncooperative. His guished white-coat-clad attending qualities I look for in my physicians are behavior at home was even worse and physicians.
    [Show full text]
  • The CNCF Handbook for Parents of Children with Neuroblastoma
    The CNCF Handbook for Parents of Children with Neuroblastoma The CNCF Handbook for Parents of Children with Neuroblastoma Acknowledgements Disclaimer Navigating Neuroblastoma and This Handbook (Read This First!) i Chapter 1 Confronting the Diagnosis 101 What is NB: Description, Diagnosis, and Staging 1:010 102 What is NB: Tumor Pathology and Genetics 1:020 103 What is NB: Risk Assignment 1:030 104 Questions for Your Doctors 1:040 105 U.S. Neuroblastoma Specialists 1:050 106 What is a Clinical Trial? 1:060 107 The World of Hospitals 1:070 108 Patients' Rights & Responsibilities 109 Reaching Out and Accepting Help 1:090 Chapter 2 Understanding the Basics of Frontline Treatments 201 Overview of Low- and Intermediate-Risk Treatment 202 Overview of High-Risk Treatment 2:020 Chapter 3 Coping with Treatment: Side Effects, Comfort, and Safety 301 What is Palliative Care? 302 Getting Through Chemotherapy 3:020 303 Surviving Neutropenia 3:030 304 Special Issues with Stem Cell Transplant(s) 3:040 305 Surgery 306 Central Venous Lines: Broviacs, Hickmans, & Ports 307 Radiation: From Tattoos to Side Effects 308 Coping with ch14.18 Antibodies 309 Coping with 3F8 Antibodies 3:090 310 Coping with 8H9 Intrathecal Antibodies 3:100 311 Coping with Accutane 3:110 312 Coping with MIBG Treatment 3:120 313 Advocating for Your Child 3:130 314 Special Issues for Teenagers and Adults © 2008 Children’s Neuroblastoma Cancer Foundation www.nbhope.org revised 6/29/2009 Table of Contents Chapter 4 Getting Through Tests & Scans 400 Introduction to Getting through Tests
    [Show full text]
  • Croi 2021 Program Committee
    General Information CONTENTS WELCOME . 2 General Information General Information OVERVIEW . 2 CONTINUING MEDICAL EDUCATION . 3 CONFERENCE SUPPORT . 4 VIRTUAL PLATFORM . 5 ON-DEMAND CONTENT AND WEBCASTS . 5 CONFERENCE SCHEDULE AT A GLANCE . 6 PRECONFERENCE SESSIONS . 9 LIVE PLENARY, ORAL, AND INTERACTIVE SESSIONS, AND ON-DEMAND SYMPOSIA BY DAY . 11 SCIENCE SPOTLIGHTS™ . 47 SCIENCE SPOTLIGHT™ SESSIONS BY CATEGORY . 109 CROI FOUNDATION . 112 IAS–USA . 112 CROI 2021 PROGRAM COMMITTEE . 113 Scientific Program Committee . 113 Community Liaison Subcommittee . 113 Former Members . 113 EXTERNAL REVIEWERS . .114 SCHOLARSHIP AWARDEES . 114 AFFILIATED OR PROXIMATE ACTIVITIES . 114 EMBARGO POLICIES AND SOCIAL MEDIA . 115 CONFERENCE ETIQUETTE . 115 ABSTRACT PROCESS Scientific Categories . 116 Abstract Content . 117 Presenter Responsibilities . 117 Abstract Review Process . 117 Statistics for Abstracts . 117 Abstracts Related to SARS-CoV-2 and Special Study Populations . 117. INDEX OF SPECIAL STUDY POPULATIONS . 118 INDEX OF PRESENTING AUTHORS . .122 . Version 9 .0 | Last Update on March 8, 2021 Printed in the United States of America . © Copyright 2021 CROI Foundation/IAS–USA . All rights reserved . ISBN #978-1-7320053-4-1 vCROI 2021 1 General Information WELCOME TO vCROI 2021 Welcome to vCROI 2021! The COVID-19 pandemic has changed the world for all of us in so many ways . Over the past year, we have had to put some of our HIV research on hold, learned to do our research in different ways using different tools, to communicate with each other in virtual formats, and to apply the many lessons in HIV research, care, and community advocacy to addressing the COVID-19 pandemic . Scientists and community stakeholders who have long been engaged in the endeavor to end the epidemic of HIV have pivoted to support and inform the unprecedented progress made in battle against SARS-CoV-2 .
    [Show full text]
  • An Interview with Leonard Zon
    © 2014. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2014) 7, 735-738 doi:10.1242/dmm.016642 A MODEL FOR LIFE From fish tank to bedside in cancer therapy: an interview with Leonard Zon Leonard Zon, who is based at Harvard Medical School, is internationally recognized for his pioneering work in hematology and stem cell biology. His lab uses zebrafish as a model to understand blood cell development and, in recent years, has made inspiring breakthroughs in the treatment of blood diseases and cancer, helping to establish zebrafish as a powerful model for translational research. In this interview, Leonard speaks to Disease Models & Mechanisms Editor-in-Chief, Ross Cagan, about the evolution of his career from developmental biologist to physician-scientist and the stories behind some of his major research accomplishments. He also discusses challenges and opportunities in zebrafish research and provides advice on translating basic research findings to the clinic. Leonard (Len) I. Zon was born in Hartford, CT, USA. He received his undergraduate degree in Chemistry and Natural Sciences from Muhlenberg College in Allentown, PA and, in 1983, obtained an M.D. degree from Jefferson Medical College in neighboring city Philadelphia. While undertaking clinical training at Deaconess Let’s start with your background. Why did you end up Medical Center, he was appointed a fellow in medical oncology at becoming a physician and also a scientist? Dana-Farber Cancer Institute. As a post-doctoral research associate The evolution of my career started while I was in college. I was in Stuart Orkin’s lab, Len sought to understand how specific blood doing research just to try it out but I didn’t really think that it was lineages are programmed at the molecular level.
    [Show full text]
  • CELEBRATION of SCIENCE
    CELEBRATION of SCIENCE COVID Lessons Learned: Scientific and Community Impact 72ND MEETING OF THE MGH SCIENTIFIC ADVISORY COMMITTEE Wednesday, April 7 & Thursday, April 8, 2021 Table of Contents 2–3 90–229 Meeting Agenda Department Reports 4 90 Anesthesia, Critical Care and P ain Medicine Martin Research Prizes 94 Cancer Center 5 98 The Consortia for Improving Medicine with Innovation Howard M. Goodman Fellowship & Technology 6–7 102 Dermatology SAC Membership 106 Emergency Medicine 110 Medicine 8–9 122 Molecular Biology ECOR Membership 126 Neurology 10–61 132 Neurosurgery MGRI Executive Report 136 Nursing 140 Obstetrics and Gynecology 62–69 148 Ophthalmology Programmatic Report 154 Oral and Maxillofacial 62 Center for Diversity Surgery and Inclusion (CDI) 158 Orthopaedics 64 Center for Faculty 168 Otolaryngology, Head and Development (CFD) Neck Surgery 176 Pathology 70–89 180 Pediatrics Thematic Center Report 194 Psychiatry 70 Center for Computational 198 Radiation Oncology and Integrative Biology 204 Radiology 74 Center for Genomic 208 Ragon Institute of MGH, Medicine MIT & Harvard 78 Center for Regenerative 210 Surgery Medicine 220 Urology 82 Center for Systems Biology 86 Wellman Center for Photomedicine Front cover photo thanks to Dylan Parsons, BS, Ragon Institute of MGH, MIT and Harvard (dylanparsonsphotography.com) Celebration of Science 3 Agenda Wednesday, April 7, 2021 11:00 AM – 1:00 PM Virtual Poster Session 2:00 – 5:00 PM Celebration Of Science Welcome and Opening Remarks Peter L. Slavin, MD, President, MGH ECOR Report David
    [Show full text]
  • At Least 18 Killed in Myanmar As Police Open Fire at Protests
    P2JW060000-5-A00100-17FFFF5178F ADVERTISEMENT Real value is morethan just apricetag. Learn moreonpage B10. ***** MONDAY,MARCH 1, 2021 ~VOL. CCLXXVII NO.48 WSJ.com HHHH $4.00 Last week: DJIA 30932.37 g 561.95 1.8% NASDAQ 13192.35 g 4.9% STOXX 600 404.99 g 2.4% 10-YR. TREASURY g 1 2/32 , yield 1.459% OIL $61.50 À $2.24 EURO $1.2074 YEN 106.56 Tehran What’s News Rejects EU Call Business&Finance For Talks urope is buying elec- Etric vehicles at arecord pace and has overtaken With U.S. China as the world’sbiggest EV market, as consumers are encouraged by govern- Iran’s push for easing ment subsidies and dozens of sanctions imperils of newcarsand hybrids. A1 hopes for revival of Jane Fraser takesover as Citigroup’sCEO with agoal of 2015 nuclear accord simplifying the giant bank at atime when it is struggling Iran rejected aEuropean to keep up with rivals. B1 Union offer to hold direct nu- February’s government- clear talks with the U.S. in the bond rout has rattled in- coming days,risking renewed vestor certainty that ul- tension between Tehran and tralow long-term interest Western capitals. rates are here to stay. B1 Herbalife plans to over- By Laurence Norman haul its board as Icahn in Brussels and winds down his involvement Michael R. Gordon with the company and it REUTERS in Washington Protesterstakecoverinaclash with riotpoliceinYangon on Sunday. Security forces openedfireoncrowdsinseveral cities. looks to burnish itsstanding Senior Western diplomats with other investors. B1 said Iran’s response doesn’t Berkshire posted a big- quash the Biden administra- ger quarterly profit, with At Least18Killed in Myanmar tion’shopes of reviving diplo- Buffett using his annual matic effortstorestorethe 2015 letter to explain a recent nuclear deal, struck between surge in stock buybacks.
    [Show full text]